Page last updated: 2024-08-23

paroxetine and Hot Flashes

paroxetine has been researched along with Hot Flashes in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	21 (48.84)	29.6817
2010's	21 (48.84)	24.3611
2020's	1 (2.33)	2.80

Authors

Authors	Studies
Crandall, CJ; Manson, JE; Mehta, JM	1
Bhaskar, S; Kaunitz, AM; Kazempour, K; Lippman, J; Mekonnen, H; Portman, DJ; Simon, JA	1
Kaplan, M; Mahon, SM	1
Bhaskar, S; Kaunitz, AM; Kazempour, K; Lippman, J; Mekonnen, H; Portman, DJ	1
Chandler, J; Denker, AE; Gottesdiener, K; He, W; Lazarus, N; Rosenberg, E; Simon, JA; Wagner, JA	1
Thacker, HL; Weber, L	1
Guo, J; Joffe, HV; Kim, MJ; Li, L; Orleans, RJ; Sobhan, M; Soule, L	1
Handley, AP; Williams, M	1
Pines, A	1
Carris, N; Kutner, S; Reilly-Rogers, S	1
Bachmann, G	1
Champion, MN; Palmore, KB; Slaton, RM	1
Bhaskar, S; Joffe, H; Kazempour, K; Lippman, J; Mekonnen, H; Pinkerton, JV	1
Jacob, JA	1
Pinkerton, JV	1
Chen, Y; Wang, Q; Wang, XQ; Wei, D; Wu, C; Wu, Q; Yang, KH; Yao, L	1
Aloisi, A; Angioli, R; Capriglione, S; Lopez, S; Luvero, D; Montera, R; Plotti, F; Scaletta, G; Serra, GB	1
Crider, M; Hill, DA; Hill, SR	1
Irahara, M; Kase, Y; Noguchi, M; Numata, S; Ohmori, T; Tsuchiya, N; Uemura, H; Ueno, S; Yamada, M; Yasui, T; Yuzurihara, M	1
Appiani, F; Carroll, BT; Muñoz, C; Trecco, J	1
Andrade, C	1
Beebe, KL; Dube, E; Iyengar, M; Stearns, V	1
Yonkers, KA	1
Goetz, MP; Loprinzi, CL	1
Stearns, V	2
Barton, DL; Carpenter, LA; Christensen, BJ; Gettman, MT; Loprinzi, CL; Novotny, PJ; Sloan, JA	1
Garber, K	1
Adelson, KB; Hershman, DL; Loprinzi, CL	1
Bunnell, C; Cullen, J; Gallagher, A; Gehan, E; Greep, N; Hayes, DF; Henry-Tilman, R; Isaacs, C; Osborne, M; Slack, R; Stearns, V; Ullmer, L	1
Baber, R; Hickey, M; Kwik, M	1
Albertazzi, P	1
Fuji, K; Fukagai, T; Naoe, M; Ogawa, Y; Shichijo, T; Yoshida, H	1
Alexander, IM; Moore, A	1
Egawa, T; Ikeda, M; Kataoka, Y; Koga, A; Shuto, H; Sohda, Y; Tominaga, K; Yamauchi, A	1
Cohen, LS; Joffe, H; Petrillo, L; Rydzewski, M; Soares, CN; Somley, B; Viguera, AC; Yehezkel, R	1
Tong, IL	1
Crawford, J; Ellis, MJ; Hanfelt, JJ; Hayes, DF; Isaacs, C; Kramer, R; Lawrence, W; Rowland, J; Stearns, V	1
Jacobsen, PB; Minton, S; Moncello, J; Weitzner, MA	1

Reviews

15 review(s) available for paroxetine and Hot Flashes

Article	Year
Management of Menopausal Symptoms: A Review. JAMA, 2023, 02-07, Volume: 329, Issue:5 Topics: Autonomic Nervous System Diseases; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasms; Paroxetine; Sweating; Venlafaxine Hydrochloride; Venous Thromboembolism	2023
Paroxetine: a first for selective serotonin reuptake inhibitors - a new use: approved for vasomotor symptoms in postmenopausal women. Women's health (London, England), 2014, Volume: 10, Issue:2 Topics: Body Temperature Regulation; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Postmenopause; Selective Serotonin Reuptake Inhibitors; Sweating; Vasomotor System	2014
The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review. Journal of the American Association of Nurse Practitioners, 2015, Volume: 27, Issue:1 Topics: Adult; Aged; Citalopram; Desvenlafaxine Succinate; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vasomotor System; Venlafaxine Hydrochloride	2015
New pharmacological therapies for vasomotor symptom management: focus on bazedoxifene/conjugated estrogens and paroxetine mesylate. The Annals of pharmacotherapy, 2014, Volume: 48, Issue:10 Topics: Clinical Trials as Topic; Drug Combinations; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Mesylates; Paroxetine; Vasomotor System	2014
A review of paroxetine for the treatment of vasomotor symptoms. Journal of pharmacy practice, 2015, Volume: 28, Issue:3 Topics: Antidepressive Agents, Second-Generation; Female; Hot Flashes; Humans; Menopause; Paroxetine	2015
Effect and safety of paroxetine for vasomotor symptoms: systematic review and meta-analysis. BJOG : an international journal of obstetrics and gynaecology, 2016, Volume: 123, Issue:11 Topics: Adult; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Perimenopause; Postmenopause; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Vasomotor System	2016
Hormone Therapy and Other Treatments for Symptoms of Menopause. American family physician, 2016, Dec-01, Volume: 94, Issue:11 Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Therapy, Combination; Dyspareunia; Estrogen Replacement Therapy; Estrogens; Exercise Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypnosis; Indoles; Menopause; Paroxetine; Progestins; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vasomotor System; Venlafaxine Hydrochloride	2016
Paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashes. Psychopharmacology bulletin, 2003,Spring, Volume: 37 Suppl 1 Topics: Antidepressive Agents, Second-Generation; Female; Hot Flashes; Humans; Menopause; Mood Disorders; Paroxetine; Premenstrual Syndrome	2003
A hot flash on tamoxifen metabolism. Journal of the National Cancer Institute, 2003, Dec-03, Volume: 95, Issue:23 Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cyclohexanols; Cytochrome P-450 CYP2D6; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Fluoxetine; Hot Flashes; Humans; Hydroxylation; Paroxetine; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Venlafaxine Hydrochloride	2003
Management of hot flashes in breast cancer survivors and men with prostate cancer. Current oncology reports, 2004, Volume: 6, Issue:4 Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Complementary Therapies; Contraceptives, Oral, Synthetic; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Male; Medroxyprogesterone; Menopause, Premature; Paroxetine; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Survivors; Treatment Outcome; Venlafaxine Hydrochloride	2004
Treatment of hot flushes in breast and prostate cancer. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:7 Topics: Amines; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cimicifuga; Contraindications; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroacupuncture; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hormone Replacement Therapy; Hot Flashes; Humans; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Paroxetine; Phytotherapy; Plant Preparations; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors	2005
Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations. Drug safety, 2005, Volume: 28, Issue:12 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Clonidine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Behavior; Hot Flashes; Humans; Menopause; Norpregnenes; Paroxetine; Personal Health Services; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen	2005
Noradrenergic and serotonergic modulation to treat vasomotor symptoms. The journal of the British Menopause Society, 2006, Volume: 12, Issue:1 Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride	2006
Treating vasomotor symptoms of menopause: the nurse practitioner's perspective. Journal of the American Academy of Nurse Practitioners, 2007, Volume: 19, Issue:3 Topics: Adrenergic alpha-Agonists; Algorithms; Amines; Citalopram; Clonidine; Complementary Therapies; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Life Style; Menopause; Middle Aged; Nurse Practitioners; Paroxetine; Patient Education as Topic; Patient Selection; Practice Guidelines as Topic; Primary Health Care; Safety Management; Selective Serotonin Reuptake Inhibitors	2007
Treatment of menopausal hot flashes. Medicine and health, Rhode Island, 2008, Volume: 91, Issue:3 Topics: Aged; Complementary Therapies; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2008

Trials

13 trial(s) available for paroxetine and Hot Flashes

Article	Year
Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials. Menopause (New York, N.Y.), 2013, Volume: 20, Issue:10 Topics: Adult; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Placebos; Postmenopause; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2013
Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:10 Topics: Adult; Aged; Body Mass Index; Body Weight; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Single-Blind Method	2014
Diary of hot flashes reported upon occurrence: results of a randomized double-blind study of raloxifene, placebo, and paroxetine. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:9 Topics: Adult; Double-Blind Method; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Medical Records; Menopause; Middle Aged; Paroxetine; Raloxifene Hydrochloride; Reproducibility of Results; Selective Estrogen Receptor Modulators; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2014
Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause. Menopause (New York, N.Y.), 2015, Volume: 22, Issue:1 Topics: Adult; Aged; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Placebos; Postmenopause; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Sleep; Sleep Wake Disorders	2015
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial. Gynecologic oncology, 2016, Volume: 143, Issue:3 Topics: Adult; Aged; Double-Blind Method; Female; Genital Neoplasms, Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Survivors; Treatment Outcome	2016
Changes in circulating cytokine levels in midlife women with psychological symptoms with selective serotonin reuptake inhibitor and Japanese traditional medicine. Maturitas, 2009, Feb-20, Volume: 62, Issue:2 Topics: Administration, Oral; Climacteric; Cytokines; Depression; Drugs, Chinese Herbal; Hot Flashes; Humans; Magnoliopsida; Medicine, East Asian Traditional; Middle Aged; Paroxetine; Phytotherapy; Plant Extracts; Selective Serotonin Reuptake Inhibitors	2009
Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA, 2003, Jun-04, Volume: 289, Issue:21 Topics: Adult; Aged; Delayed-Action Preparations; Double-Blind Method; Female; Health Status Indicators; Hot Flashes; Humans; Logistic Models; Menopause; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2003
Pilot evaluation of paroxetine for treating hot flashes in men. Mayo Clinic proceedings, 2004, Volume: 79, Issue:10 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Dose-Response Relationship, Drug; Hot Flashes; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Prospective Studies; Prostatic Neoplasms; Selective Serotonin Reuptake Inhibitors	2004
Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Oct-01, Volume: 23, Issue:28 Topics: Adult; Aged; Breast Neoplasms; Cross-Over Studies; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Patient Compliance; Placebos; Quality of Life; Selective Serotonin Reuptake Inhibitors	2005
Pilot evaluation of selective serotonin reuptake inhibitor antidepressants in hot flash patients under androgen-deprivation therapy for prostate cancer. Prostate cancer and prostatic diseases, 2006, Volume: 9, Issue:3 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antidepressive Agents; Carcinoma; Dose-Response Relationship, Drug; Hot Flashes; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Prostatic Neoplasms; Selective Serotonin Reuptake Inhibitors	2006
Paroxetine versus placebo for women in midlife after hormone therapy discontinuation. The American journal of medicine, 2008, Volume: 121, Issue:2 Topics: Adult; Depression; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome	2008
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:1 Topics: Adult; Aged; Anxiety; Breast Neoplasms; Confidence Intervals; Depression; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Pilot Projects; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Surveys and Questionnaires; Survivors	2000
A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. Journal of pain and symptom management, 2002, Volume: 23, Issue:4 Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Depression; Fatigue; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders	2002

Other Studies

15 other study(ies) available for paroxetine and Hot Flashes

Article	Year
Paroxetine (Brisdelle) for hot flashes. The Medical letter on drugs and therapeutics, 2013, Oct-28, Volume: 55, Issue:1428 Topics: Drug Interactions; Female; Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors	2013
Paroxetine approval. The American journal of nursing, 2014, Volume: 114, Issue:1 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Antagonism; Female; Hot Flashes; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tamoxifen	2014
FDA approval of paroxetine for menopausal hot flushes. The New England journal of medicine, 2014, May-08, Volume: 370, Issue:19 Topics: Advisory Committees; Antineoplastic Agents, Hormonal; Cytochrome P-450 CYP2D6; Drug Approval; Drug Interactions; Female; Hot Flashes; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Suicidal Ideation; Tamoxifen; United States; United States Food and Drug Administration	2014
Safety of low-dose paroxetine. Climacteric : the journal of the International Menopause Society, 2014, Volume: 17, Issue:3 Topics: Body Weight; Female; Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological	2014
Another option for menopausal vasomotor symptoms without negative impact on weight and sexual function. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:10 Topics: Body Weight; Female; Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological	2014
Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause (New York, N.Y.), 2015, Volume: 22, Issue:11 Topics: Behavior Therapy; Cognitive Behavioral Therapy; Exercise; Female; Health Education; Hot Flashes; Humans; Menopause; Paroxetine; Practice Guidelines as Topic; Relaxation; Societies, Medical; United States; Vascular Diseases; Vasomotor System; Women's Health; Yoga	2015
Can Nonhormonal Treatments Dial Down the Heat During Menopause? JAMA, 2016, Jan-05, Volume: 315, Issue:1 Topics: Advisory Committees; Antidepressive Agents; Cognitive Behavioral Therapy; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Hypnosis; Menopause; Paroxetine; Phytotherapy; Selective Serotonin Reuptake Inhibitors; Stellate Ganglion	2016
Dose is important for nonhormonal therapy for hot flashes. BJOG : an international journal of obstetrics and gynaecology, 2016, Volume: 123, Issue:11 Topics: Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors	2016
Tamoxifen-SSRIs interaction: clinical manifestations of inhibition and lack of inhibition of CYP2D6. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2011, Volume: 23, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal; Citalopram; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder, Major; Drug Interactions; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tamoxifen	2011
Breast cancer and antidepressant use. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:9 Topics: Adult; Aged; Antidepressive Agents; Anxiety; Breast Neoplasms; Contraindications; Cytochrome P-450 CYP2D6 Inhibitors; Depression; Drug Interactions; Female; Hot Flashes; Humans; Paroxetine; Prodrugs; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen	2012
Tamoxifen pharmacogenetics moves closer to reality. Journal of the National Cancer Institute, 2005, Mar-16, Volume: 97, Issue:6 Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Enzyme Inhibitors; Estrogen Receptor Modulators; Genotype; Hot Flashes; Humans; Paroxetine; Pharmacogenetics; Polymorphism, Genetic; Predictive Value of Tests; Tamoxifen	2005
A drug may help hot flashes after prostate cancer treatment. Mayo Clinic health letter (English ed.), 2005, Volume: 23, Issue:3 Topics: Antidepressive Agents, Second-Generation; Hot Flashes; Humans; Male; Paroxetine; Prostatic Neoplasms	2005
Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms. Treatments in endocrinology, 2006, Volume: 5, Issue:2 Topics: Antineoplastic Agents, Hormonal; Hot Flashes; Humans; Menopause; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors	2006
Selective serotonin reuptake inhibitors fluvoxamine and paroxetine restore forced exercise-induced temperature dysregulation in ovariectomized mice. European journal of pharmacology, 2008, Jan-28, Volume: 579, Issue:1-3 Topics: Animals; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Fluvoxamine; Hot Flashes; Humans; Menopause; Mice; Mice, Inbred ICR; Models, Animal; Ovariectomy; Paroxetine; Physical Conditioning, Animal; Selective Serotonin Reuptake Inhibitors; Skin Temperature; Tail	2008
Breast cancer and hot flashes. Options for relief. Mayo Clinic health letter (English ed.), 2001, Volume: 19, Issue:3 Topics: Breast Neoplasms; Cyclohexanols; Female; Hot Flashes; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001